Literature DB >> 16130103

Two types of chromosome 1p losses with opposite significance in gliomas.

Ahmed Idbaih1, Yannick Marie, Gaëlle Pierron, Caroline Brennetot, Khê Hoang-Xuan, Michèle Kujas, Karima Mokhtari, Marc Sanson, Julie Lejeune, Alain Aurias, Olivier Delattre, Jean-Yves Delattre.   

Abstract

Deletion of the short arm of chromosome 1 (1p) is considered a favorable prognostic factor in glial tumors. High-density array-comparative genomic hybridization analysis of 108 gliomas shows two distinct types of 1p deletions. Complete hemizygous losses of 1p, which are tightly associated with 19q loss and oligodendroglial phenotype, and partial 1p deletions mainly observed in astrocytic tumors and not associated with 19q loss. Whereas the first type predicts longer overall and progression-free survival (p < 0.0001), the second type has a pejorative prognostic value. Complete 1p-arm evaluation therefore is required to appreciate the real clinical significance of 1p loss in gliomas.

Entities:  

Mesh:

Year:  2005        PMID: 16130103     DOI: 10.1002/ana.20607

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  43 in total

1.  Wilms' tumor in patients with 9q22.3 microdeletion syndrome suggests a role for PTCH1 in nephroblastomas.

Authors:  Bertrand Isidor; Franck Bourdeaut; Delfine Lafon; Ghislaine Plessis; Elodie Lacaze; Caroline Kannengiesser; Sylvie Rossignol; Olivier Pichon; Annaig Briand; Dominique Martin-Coignard; Maria Piccione; Albert David; Olivier Delattre; Cécile Jeanpierre; Nicolas Sévenet; Cédric Le Caignec
Journal:  Eur J Hum Genet       Date:  2012-11-21       Impact factor: 4.246

2.  Velocity of tumor spontaneous expansion predicts long-term outcomes for diffuse low-grade gliomas.

Authors:  Johan Pallud; Marie Blonski; Emmanuel Mandonnet; Etienne Audureau; Denys Fontaine; Nader Sanai; Luc Bauchet; Philippe Peruzzi; Marc Frénay; Philippe Colin; Rémy Guillevin; Valérie Bernier; Marie-Hélène Baron; Jacques Guyotat; Hugues Duffau; Luc Taillandier; Laurent Capelle
Journal:  Neuro Oncol       Date:  2013-02-07       Impact factor: 12.300

3.  Multiplex ligation-dependent probe amplification: a diagnostic tool for simultaneous identification of different genetic markers in glial tumors.

Authors:  Judith Jeuken; Sandra Cornelissen; Sandra Boots-Sprenger; Sabine Gijsen; Pieter Wesseling
Journal:  J Mol Diagn       Date:  2006-09       Impact factor: 5.568

Review 4.  Biology, genetics and imaging of glial cell tumours.

Authors:  C Walker; A Baborie; D Crooks; S Wilkins; M D Jenkinson
Journal:  Br J Radiol       Date:  2011-12       Impact factor: 3.039

5.  Alternative lengthening of telomeres: recurrent cytogenetic aberrations and chromosome stability under extreme telomere dysfunction.

Authors:  Despoina Sakellariou; Maria Chiourea; Christina Raftopoulou; Sarantis Gagos
Journal:  Neoplasia       Date:  2013-11       Impact factor: 5.715

Review 6.  Molecular markers of glioma: an update on recent progress and perspectives.

Authors:  Kirti Gupta; Pravin Salunke
Journal:  J Cancer Res Clin Oncol       Date:  2012-10-06       Impact factor: 4.553

7.  Molecular Diagnostic and Prognostic Subtyping of Gliomas in Tunisian Population.

Authors:  Saoussen Trabelsi; Imen Chabchoub; Iadh Ksira; Nadhir Karmeni; Nadia Mama; Samia Kanoun; Anna Burford; Alexa Jury; Alan Mackay; Sergey Popov; Noureddine Bouaouina; Slim Ben Ahmed; Moncef Mokni; Kalthoum Tlili; Hedi Krifa; Mohamed Tahar Yacoubi; Chris Jones; Ali Saad; Dorra H'mida Ben Brahim
Journal:  Mol Neurobiol       Date:  2016-03-09       Impact factor: 5.590

8.  Clinical relevance of 1p and 19q deletion for patients with WHO grade 2 and 3 gliomas.

Authors:  Fabio M Iwamoto; Linda Nicolardi; Alexis Demopoulos; Violetta Barbashina; Paulo Salazar; Marc Rosenblum; Adília Hormigo
Journal:  J Neurooncol       Date:  2008-03-15       Impact factor: 4.130

9.  Prevalence, clinico-pathological value, and co-occurrence of PDGFRA abnormalities in diffuse gliomas.

Authors:  Agustí Alentorn; Yannick Marie; Catherine Carpentier; Blandine Boisselier; Marine Giry; Marianne Labussière; Karima Mokhtari; Khê Hoang-Xuan; Marc Sanson; Jean-Yves Delattre; Ahmed Idbaih
Journal:  Neuro Oncol       Date:  2012-10-16       Impact factor: 12.300

10.  Glioblastomas: correlation between oligodendroglial components, genetic abnormalities, and prognosis.

Authors:  Luciana Wernersbach Pinto; Maria Betania Mahler Araújo; Andre L Vettore; Liana Wernersbach; André Campana C Leite; Leila Maria C Chimelli; Fernando Augusto Soares
Journal:  Virchows Arch       Date:  2008-05       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.